MRKR · Marker Therapeutics, Inc. · Webcasts, Transcripts & Audio
$1.06
+0.01 (+0.95%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding our ability to continue as a going concern. Our condensed consolidated financial statements have been prepared on a going concern basis, which implies that we will continue to realize our assets and discharge our liabilities in the normal course of business. Our financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$19.17M
Shares
16.67M
Volume · Oct 5
73.49K
Avg daily vol (3M)
69.91K
Marker Therapeutics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Marker Therapeutics, Inc. (MRKR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Earnings call
FY21 · Q3
2021-11-10
Marker Therapeutics, Inc. (MRKR) Q3 2021 Earnings Call
Diluted EPS
$-1.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-12
Marker Therapeutics, Inc. (MRKR) Q1 2021 Earnings Call Transcript
Diluted EPS
$-1.60
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-11-09
Marker Therapeutics, Inc. (MRKR) Q3 2020 Earnings Call Transcript
Revenue
$
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Marker Therapeutics, Inc. (MRKR) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–4 of 4 webcasts